Literature DB >> 28180102

Concomitant Right Ventricular Outflow Tract Cryoablation during Pulmonary Valve Replacement in a Patient with Tetralogy of Fallot.

Hong Ju Shin1, Seunghwan Song2, Yu Rim Shin2, Han Ki Park2, Young Hwan Park2.   

Abstract

A 38-year-old female patient with a history of tetralogy of Fallot repair at 10 years of age underwent pulmonary valve replacement with a mechanical prosthesis, tricuspid annuloplasty, and right ventricular outflow tract cryoablation due to pulmonary regurgitation, tricuspid regurgitation, and multiple premature ventricular contractions with sustained ventricular tachycardia. After surgery, she had an uneventful postoperative course with arrhythmia monitoring. She was discharged without incident, and a follow-up Holter examination showed a decrease in the number of ventricular ectopic beats from 702 to 41.

Entities:  

Keywords:  Cryosurgery; Pulmonary valve replacement; Right ventricular outflow tract

Year:  2017        PMID: 28180102      PMCID: PMC5295482          DOI: 10.5090/kjtcs.2017.50.1.41

Source DB:  PubMed          Journal:  Korean J Thorac Cardiovasc Surg        ISSN: 2233-601X


Case report

A 38-year-old female patient with a history of tetralogy of Fallot (TOF) repair at 10 years of age presented with arrhythmia. Electrocardiography showed atrial fibrillation with a QRS duration of 106 ms. Holter monitoring indicated 702 ventricular ectopic beats and 633 supraventricular ectopic beats, each representing 1% of the total QRS complexes. Of the 702 ventricular ectopic beats, there were 276 (39.3%) bigeminal cycles (Fig. 1A). Echocardiography revealed moderate pulmonary insufficiency, tricuspid regurgitation, and right atrial dilatation with decreased systolic function and a left ventricular ejection fraction of 45%. A cardiopulmonary exercise test revealed a decreased maximum oxygen consumption (VO2max) of 23.6 mL/kg/min. Computed tomographic imaging showed right ventricular enlargement with a right ventricular end-diastolic volume index of 216.5 mL/m2. Thus, we determined that pulmonary valve replacement (PVR), tricuspid valve repair, and arrhythmia surgery were necessary. An electrophysiological study was not performed because of an unstable heart rhythm, mainly pause-dependent torsades de pointes; therefore, an emergency operation was required. A maze procedure was not planned due to advice of arrhythmia part because of chronic atrial fibrillation, and right ventricular outflow tract (RVOT) ablation was planned because it can help reduce ventricular arrhythmia. The surgical approach was via median sternotomy, during which there were multiple premature ventricular contractions with sustained ventricular tachycardia that required lidocaine injection. During cardiopulmonary bypass, am eticulous dissection was performed. After aortic cross-clamping, right atriotomy and tricuspid annuloplasty were performed using the DeVega method to correct moderate tricuspid regurgitation. Then, the aortic cross-clamp was released, and a vertical incision was made in the main pulmonary artery with the heart contracting. After the previous thickened bovine pericardium was detached, RVOT cryoablation was performed using a Frigitronics (Cooper Surgical Inc., Trumbull, CT, USA) cryoprobe (Fig. 2). A cryoablation lesion was located around the RVOT-free wall margin and near the ventricular septal defect patch repair site, including the pulmonary annulus. The cryoablation was carried out for 60 seconds at −60°C with a 15-mm probe. After R VOT cryoablation, P VR with an On-X 25 mm (On-X Life Technologies Inc., Austin, TX, USA) and left pulmonary angioplasty for the correction of left pulmonary artery stenosis and kinking were performed. The durations of cardiopulmonary bypass and aortic cross-clamping were 265 minutes and 37 minutes, respectively. The patient had an uneventful postoperative course with arrhythmia monitoring and was discharged on postoperative day 30. A follow-up Holter examination 28 days after surgery revealed 41 ventricular ectopic beats (<1% of the total QRS complexes) and no supraventricular ectopic beats. A follow-up electrocardiogram 14 months later showed atrial fibrillation with a decreased QRS duration of 92 ms (Fig. 1B). The patient was well at the most recent follow-up, with no signs of dyspnea or chest discomfort.
Fig. 1

(A) Preoperative EKG shows multiple bigeminal cycles, and (B) postoperative EKG shows atrial fibrillation with a narrow QRS. EKG, electrocardiography.

Fig. 2

The cryoablation lesion was located around the previous suture margin of the bovine pericardium, consisting of the right ventricular free wall, excluding the main pulmonary artery tissue. Another cryoablation was performed vertically from the ventricular septum next to the ventricular septal defect patch to the pulmonary annulus. Cryoablation was performed for 60 seconds at −60°C with a 15-mm cryoprobe.

Discussion

Pulmonary insufficiency after surgical or interventional relief of pulmonary stenosis can lead to progressive right ventricular dilatation, arrhythmia, exercise intolerance, or even sudden death. If the duration of pulmonary regurgitation is prolonged, ventricular arrhythmia usually develops; however, the evaluation and management of ventricular arrhythmia is not currently standardized. TOF patients with a severely prolonged QRS duration (>180 ms) are at risk for adverse events [1], but other factors related to ventricular arrhythmia are not well known. Pulmonary insufficiency after TOF repair, loading volume, and right ventricular dysfunction often lead to the development of ventricular arrhythmia; thus, PVR itself can reduce the incidence of ventricular arrhythmia. However, some patients have poor outcomes even after PVR [2]. At present, electophysiologic studies including intracardiac mapping and ablation have confirmed that ventricular tachycardia is typically of a macro-re-entrant nature, using cardiac valves and ventricular scars as boundaries [3,4]. Therefore, surgical ablation of the RVOT is a logical approach for isolating diseased substrates [2,5,6]. On the basis of this knowledge, we performed concomitant PVR and RVOT cryoablation. Although RVOT cryoablation has been used since the early 2000s [7], there are no standard surgical ablation guidelines. A major concern with the cryoablation procedure is the conduction block. Additionally, if the lesion is not completely ablated, a remnant lesion can serve as a substrate, resulting in slow cardiac conduction and re-entrant arrhythmia. In such cases, we expect the RVOT suture margin and the ventricular septal defect patch repair site to cause arrhythmia, and these sites should therefore be ablated. Whether this patient received a rhythmic advantage from PVR, which reduces the hemodynamic burden, or RVOT cryoablation, which eliminated the arrhythmic substrate, is still to be determined. However, surgical cryoablation of the RVOT itself appears to be safe and reduces the risk of arrhythmic events after PVR.
  7 in total

1.  Follow-up after pulmonary valve replacement in adults with tetralogy of Fallot: association between QRS duration and outcome.

Authors:  Roderick W C Scherptong; Mark G Hazekamp; Barbara J M Mulder; Olivier Wijers; Cees A Swenne; Ernst E van der Wall; Martin J Schalij; Hubert W Vliegen
Journal:  J Am Coll Cardiol       Date:  2010-10-26       Impact factor: 24.094

2.  Serial follow-up of adults with repaired tetralogy of Fallot.

Authors:  S A Waien; P P Liu; B L Ross; W G Williams; G D Webb; P R McLaughlin
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

3.  Impact of pulmonary valve replacement on arrhythmia propensity late after repair of tetralogy of Fallot.

Authors:  J Therrien; S C Siu; L Harris; A Dore; K Niwa; J Janousek; W G Williams; G Webb; M A Gatzoulis
Journal:  Circulation       Date:  2001-05-22       Impact factor: 29.690

4.  Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot.

Authors:  D A Harrison; L Harris; S C Siu; C J MacLoghlin; M S Connelly; G D Webb; E Downar; P R McLaughlin; W G Williams
Journal:  J Am Coll Cardiol       Date:  1997-11-01       Impact factor: 24.094

5.  Ventricular arrhythmia risk stratification in patients with tetralogy of Fallot at the time of pulmonary valve replacement.

Authors:  Anna Sabate Rotes; Heidi M Connolly; Carole A Warnes; Naser M Ammash; Sabrina D Phillips; Joseph A Dearani; Hartzell V Schaff; Harold M Burkhart; David O Hodge; Samuel J Asirvatham; Christopher J McLeod
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-11-21

Review 6.  Opportunities in pulmonary valve replacement.

Authors:  Thomas Oosterhof; Mark G Hazekamp; Barbara J M Mulder
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-09

7.  Pulmonary valve replacement in tetralogy of Fallot: impact on survival and ventricular tachycardia.

Authors:  David M Harrild; Charles I Berul; Frank Cecchin; Tal Geva; Kimberlee Gauvreau; Frank Pigula; Edward P Walsh
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.